NBE

Life Science Cares Launches in Switzerland

Retrieved on: 
Freitag, April 19, 2024
HBM, Partner, Risk, Swiss Red Cross, LSCS, NBE, SBA, Roche, Poverty, Biotechnology, Cooley LLP, Therapy, Marriott Hotels & Resorts, Molecular Partners

ZURICH, Switzerland, April 19, 2024 (GLOBE NEWSWIRE) -- Today, Life Science Cares, a collective effort of the life science industry to reduce the impact of poverty and inequality in their communities, launched in Switzerland, marking its first expansion as an independent association into geographies outside of the United States.

Key Points: 
  • ZURICH, Switzerland, April 19, 2024 (GLOBE NEWSWIRE) -- Today, Life Science Cares, a collective effort of the life science industry to reduce the impact of poverty and inequality in their communities, launched in Switzerland, marking its first expansion as an independent association into geographies outside of the United States.
  • “We are excited to launch Life Science Cares Switzerland (LSCS) today, in time, to engage with the local community at the upcoming Swiss Biotech Day in Basel,” said Nadine Zahnd, Managing Director of LSCS.
  • “At the heart of our life sciences community is the overwhelming sense to act and do good.
  • We are building bridges between Swiss Life Science Organizations and local charitable organizations for individuals who may otherwise fail to access the opportunities afforded to so many of us.”
    In Switzerland in 2021, 1.24 million people, including many families are considered at the brink of poverty.

Nasdaq Completes Migration of the Third U.S. Market to AWS

Retrieved on: 
Dienstag, November 14, 2023
Risk management, Fintech, NBE, Risk, NDAQ, Amazon Web Services, Equinix, FMI, AWS, Environment, Cryptocurrency

NEW YORK, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ) today announced it has successfully completed the migration of the core trading system of Nasdaq GEMX, one of Nasdaq's six options exchanges, to Amazon Web Services (AWS).

Key Points: 
  • NEW YORK, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ) today announced it has successfully completed the migration of the core trading system of Nasdaq GEMX, one of Nasdaq's six options exchanges, to Amazon Web Services (AWS).
  • Nasdaq GEMX is Nasdaq's third market to accomplish the move to AWS following Nasdaq MRX in 2022 and the Nasdaq Bond Exchange (NBE) earlier in 2023.
  • Nasdaq successfully handled enormous volumes of message traffic while managing a wide array of real-time market conditions, ensuring a seamless experience for market participants.
  • Nasdaq continues to lead in market modernization by delivering cloud-enabled infrastructure and building a more resilient, scalable and accessible financial ecosystem.

LRN and Nordic Business Ethics Initiative to collaborate with the 2023 survey

Retrieved on: 
Mittwoch, August 30, 2023
Education, Training, Professional Services, Human Resources, LRN, Research, NBE, E&C, Organization, Ethics, Data, Benchmarking, Ethics & Compliance Initiative, Nordic

LRN Corporation , the leader in ethics and compliance solutions that enable organizations to inspire principled performance, today announces a collaboration with the Nordic Business Initiative (NBE) to deliver deeper insights into ethics and compliance (E&C) issues across the Nordic region.

Key Points: 
  • LRN Corporation , the leader in ethics and compliance solutions that enable organizations to inspire principled performance, today announces a collaboration with the Nordic Business Initiative (NBE) to deliver deeper insights into ethics and compliance (E&C) issues across the Nordic region.
  • LRN will be the exclusive provider of global E&C benchmarking data to NBE, which will give additional global context to the organization’s bi-annual ‘Nordic Ethics & Compliance Survey’ for the first time.
  • Nordic Ethics & Compliance Survey reports on trends in the state of ethics & compliance programs in the Nordic region.
  • “The Nordic Business Ethics Initiative is doing vital work in building awareness of ethics and compliance across the Nordic region, and its research is a critical tool when it comes to understanding the state of play so that key issues can be addressed,” said Kevin Michielsen, CEO of LRN.

Rocky Mountain High Brands Business Growth Prompts Relocation

Retrieved on: 
Donnerstag, Juli 6, 2023
Eagle, Drink, Culture, OTC Markets Group, Symbolism, NBE, History, Creativity, Soil, Water, OTC, CBD, Growth, Bottled water

PLANO, Texas, July 06, 2023 (GLOBE NEWSWIRE) -- Rocky Mountain High Brands, Inc. (OTC: RMHB) today announced that it has relocated its corporate headquarters and its production subsidiary, Rocky Mountain Productions, Inc., to 3540 14th Street in Plano, Texas.

Key Points: 
  • PLANO, Texas, July 06, 2023 (GLOBE NEWSWIRE) -- Rocky Mountain High Brands, Inc. (OTC: RMHB) today announced that it has relocated its corporate headquarters and its production subsidiary, Rocky Mountain Productions, Inc., to 3540 14th Street in Plano, Texas.
  • This new facility provides the Company with a larger space to drive brand expansion for new growth initiatives moving forward.
  • The Company’s goal is to amplify its brands’ footprint by producing beverages containing CBD and hempseed extract, which was prohibited by the ownership at the previous location.
  • Rocky Mountain High Brands, Inc. is a diversified and dynamic Company committed to making a difference by raising the quality and expectations of beverages.

Rocky Mountain High Brands Subsidiary Receives Large Purchase Order from CBD Life

Retrieved on: 
Mittwoch, März 1, 2023
Creativity, Golden, OTC, Eagle, CBD, NBE, Growth, Culture, OTC Markets Group, History, Life, Drink, Eye, Soil, Rocky Mountain High, Sale, Water, Symbolism, Pedialyte, Bottled water

PLANO, Texas, March 01, 2023 (GLOBE NEWSWIRE) -- Rocky Mountain High Brands, Inc. (OTC: RMHB) today announced that Rocky Mountain NexBev, Inc., a wholly owned subsidiary specializing in cannabis beverages, received a 1.6 million can purchase order from CBD Life for brands Rocket High, California Limonada, and California Sabor Te Negro.

Key Points: 
  • PLANO, Texas, March 01, 2023 (GLOBE NEWSWIRE) -- Rocky Mountain High Brands, Inc. (OTC: RMHB) today announced that Rocky Mountain NexBev, Inc., a wholly owned subsidiary specializing in cannabis beverages, received a 1.6 million can purchase order from CBD Life for brands Rocket High, California Limonada, and California Sabor Te Negro.
  • CBD Life is the first Mexican company to import and market CBD products in Mexico.
  • ROCKET HIGH alludes to the energy and strength of a rocket and pays homage to the Rocky Mountain High brand name.
  • Rocky Mountain High Brands, Inc. is a diversified and dynamic Company committed to making a difference by raising the quality and expectations in beverages.

PharmaForceIQ's AI-Driven Omnichannel Platform Boosts HCP Engagement Rates and NRx

Retrieved on: 
Dienstag, Februar 21, 2023
HCP, Digital, Dark Enlightenment, SOV, Human, Associate Director of National Intelligence and Chief Information Officer, NBE, Ecosystem, Third party, CRM, Health care, Marketing, Lung cancer, Partnership, Rights, Integration, NSCLC, Medscape

HINGHAM, Mass., Feb. 21, 2023 /PRNewswire/ -- PharmaForceIQ (pharmaforceiq.com), an AI-driven omnichannel platform for hyper-targeted HCP marketing, today announced impressive results from a 24-month HCP campaign for a 2nd to market NSCLC drug in which Medscape was leveraged as one of the high performing channels.

Key Points: 
  • Omnichannel Healthcare Marketing Platform, PharmaForceIQ proved the value of its proprietary HCP affinity data and delivered personalized HCP engagement with a 2X increase in HCP engagement rates.
  • The platform was able to attribute a 97% new prescription (NRx) coverage in a highly crowded lung cancer market.
  • HINGHAM, Mass., Feb. 21, 2023 /PRNewswire/ -- PharmaForceIQ (pharmaforceiq.com), an AI-driven omnichannel platform for hyper-targeted HCP marketing, today announced impressive results from a 24-month HCP campaign for a 2nd to market NSCLC drug in which Medscape was leveraged as one of the high performing channels.
  • Hence, the objective was to optimize HCP targeting efforts i.e., increase its HCP share of voice (SOV) when it matters most.

In-line UV-vis Spectroscopy Market Size, Share & Trends Analysis Report 2022: Pharmaceutical/Chemical - Global Forecast to 2030 - ResearchAndMarkets.com

Retrieved on: 
Freitag, Januar 20, 2023
Pharmaceutical, Hardware, Technology, Food, Beverage, Retail, Science, Chemicals, Plastics, Other Technology, Food Tech, Manufacturing, Other Science, Health, Internal, Pharmaceutical industry, Nuclear magnetic resonance, Laboratory, Protein, Therapy, Certified reference materials, Chemical industry, Workflow, Environmental monitoring, NBE, USP, National Institute of Standards and Technology, Indium gallium arsenide, European Pharmacopoeia, Certification, Spectrophotometry, Research, United States Pharmacopeia, Calibration, LED, Dicarboxylic acid, USD, Quality control, Pharmacy, Non-Euclidean geometry, Agriculture, IR, COVID-19, NMR, Silicon, Ultraviolet–visible spectroscopy, Sewage treatment, Speciality chemicals, Medical device, Video game

The "In-line UV-vis Spectroscopy Market Size, Share & Trends Analysis Report by Application (Color Measurement, Chemical Concentration), by End-user (Pharmaceutical Industry, Chemical Industry), and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "In-line UV-vis Spectroscopy Market Size, Share & Trends Analysis Report by Application (Color Measurement, Chemical Concentration), by End-user (Pharmaceutical Industry, Chemical Industry), and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.
  • UV/Visible spectrophotometers are widely used by laboratories, including that associated with academia and governments, as well as other industries.
  • Thus, accurate calibration of the wavelength axis is important for applications that rely on spectroscopic techniques for compound testing, to receive regulatory approval.
  • These factors have driven the use of other spectroscopy methods, thereby limiting the revenue growth in this industry.

Full-Life Technologies Announces Appointment of Steffen Heeger, MD, PhD, as Chief Medical Officer and Fa Liu, PhD, as Chief Scientific Officer

Retrieved on: 
Dienstag, Januar 17, 2023
IND, Radiopharmaceutical, Oncology, National Cancer Institute, Health, University, Lymphoma, Eli Lilly, Therapy, Merck Group, Merck, Germinal center B-cell like diffuse large B-cell lymphoma, Science, Master of Science, University Hospital Heidelberg, CD38, Organic chemistry, IPO, MD, FDA, Head, Chinese Academy of Sciences, NBE, Novo Nordisk, Boehringer Ingelheim, CSO, CD19, EGFR, RDC, Cancer, Full Life Christian Centre, Clinical trial, German Cancer Research Center, CMO, Acquisition, Doctor of Philosophy, Anti-CD19 immunotoxin, S.A, PSMA, Pharmaceutical industry, Lilly, Chemistry

MANNHEIM, Germany, WATCHUNG, N.J. and SHANGHAI, Jan. 16, 2023 /PRNewswire/ -- Full-Life Technologies today announced the appointments of Steffen Heeger, MD, PhD, as Chief Medical Officer (CMO) and Fa Liu, PhD as Chief Scientific Officer (CSO).

Key Points: 
  • MANNHEIM, Germany, WATCHUNG, N.J. and SHANGHAI, Jan. 16, 2023 /PRNewswire/ -- Full-Life Technologies today announced the appointments of Steffen Heeger, MD, PhD, as Chief Medical Officer (CMO) and Fa Liu, PhD as Chief Scientific Officer (CSO).
  • Dr. Heeger has held senior oncology clinical development positions at both large and emerging companies for more than 15 years.
  • "He joins Full-Life as we are accelerating plans for our first targeted radiopharmaceuticals to enter clinical trials.
  • Dr. Liu has had a highly successful, 18-year career in therapeutic discovery, including at Eli Lilly and Novo Nordisk.

Full-Life Technologies Announces Appointment of Steffen Heeger, MD, PhD, as Chief Medical Officer and Fa Liu, PhD, as Chief Scientific Officer

Retrieved on: 
Dienstag, Januar 17, 2023
IND, Radiopharmaceutical, Oncology, National Cancer Institute, Health, University, Lymphoma, Eli Lilly, Therapy, Merck Group, Merck, Germinal center B-cell like diffuse large B-cell lymphoma, Science, Master of Science, University Hospital Heidelberg, CD38, Organic chemistry, IPO, MD, FDA, Head, Chinese Academy of Sciences, NBE, Novo Nordisk, Boehringer Ingelheim, CSO, CD19, EGFR, RDC, Cancer, Full Life Christian Centre, Clinical trial, German Cancer Research Center, CMO, Acquisition, Doctor of Philosophy, Anti-CD19 immunotoxin, S.A, PSMA, Pharmaceutical industry, Lilly, Chemistry

MANNHEIM, Germany, WATCHUNG, N.J. and SHANGHAI, Jan. 17, 2023 /PRNewswire/ -- Full-Life Technologies today announced the appointments of Steffen Heeger, MD, PhD, as Chief Medical Officer (CMO) and Fa Liu, PhD as Chief Scientific Officer (CSO).

Key Points: 
  • MANNHEIM, Germany, WATCHUNG, N.J. and SHANGHAI, Jan. 17, 2023 /PRNewswire/ -- Full-Life Technologies today announced the appointments of Steffen Heeger, MD, PhD, as Chief Medical Officer (CMO) and Fa Liu, PhD as Chief Scientific Officer (CSO).
  • Dr. Heeger has held senior oncology clinical development positions at both large and emerging companies for more than 15 years.
  • "He joins Full-Life as we are accelerating plans for our first targeted radiopharmaceuticals to enter clinical trials.
  • Dr. Liu has had a highly successful, 18-year career in therapeutic discovery, including at Eli Lilly and Novo Nordisk.

Rocky Mountain High Brands Reports Preliminary Unaudited Record Revenue of $1.6 Million for Fourth Quarter of 2022

Retrieved on: 
Mittwoch, Januar 11, 2023
Drink, OTC, OTC Markets Group, Soil, Culture, NBE, Risk, Water, History, Growth, Creativity, Eagle, Symbolism, Bottled water, Risk management

PLANO, Texas, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Rocky Mountain High Brands, Inc. (OTC: RMHB) today announced that it expects to report record revenue of $1.6 million for the fourth quarter of 2022.

Key Points: 
  • PLANO, Texas, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Rocky Mountain High Brands, Inc. (OTC: RMHB) today announced that it expects to report record revenue of $1.6 million for the fourth quarter of 2022.
  • The fourth quarter 2022 was Rocky Mountain High Brands’ best revenue quarter to date.
  • Included in the above are preliminary unaudited revenue results for the fourth quarter of 2022.
  • Rocky Mountain High Brands, Inc. is a diversified and dynamic Company committed to making a difference by raising the quality and expectations in beverages.